Nach Davé

Nach Davé received his B.S. in Pharmacy from the University of Sciences, Philadelphia and a Masters in Regulatory Science from Long Island University, Brooklyn. He has worked in strategic positions across clinical operations and regulatory affairs for drug and device companies. In addition to industry appointments, he was previously an adjunct professor in the Drug Regulatory MS Program at Long Island University and a visiting professor at University of Southern California Keck School of Medicine.

His industry experience is full of strategic consultations on clinical trials, leading FDA and EMA engagements and developing TPPs and Development Plans for drug and device products. Mr. Davé has personally led the efforts on a variety of regulatory submissions including INDs, NDAs, BLAs, 510ks, DeNovo 510ks, and PMAs. He has been a key strategist for several MedTech start-ups and has a demonstrated track record for growing small to mid-sized healthcare companies. Currently Mr. Davé is based in Princeton, New Jersey.